Rho signaling inhibition mitigates lung injury via targeting neutrophil recruitment and selectin-AKT signaling.
Amides
/ pharmacology
Animals
Cell Movement
Cells, Cultured
Enzyme Inhibitors
/ pharmacology
Male
Mice
Mice, Inbred C57BL
Neutrophils
/ drug effects
Pneumonia
/ drug therapy
Proto-Oncogene Proteins c-akt
/ metabolism
Pyridines
/ pharmacology
Reactive Oxygen Species
/ metabolism
Selectins
/ metabolism
Signal Transduction
rho GTP-Binding Proteins
/ antagonists & inhibitors
Acute lung injury
Chemotaxis
L-selectin
Neutrophils
Rho kinase
Y-27632
Journal
Biochimica et biophysica acta. Molecular cell research
ISSN: 1879-2596
Titre abrégé: Biochim Biophys Acta Mol Cell Res
Pays: Netherlands
ID NLM: 101731731
Informations de publication
Date de publication:
11 2021
11 2021
Historique:
received:
29
01
2021
revised:
05
08
2021
accepted:
16
08
2021
pubmed:
24
8
2021
medline:
30
12
2021
entrez:
23
8
2021
Statut:
ppublish
Résumé
Neutrophils, the early responders of the immune system, eliminate intruders, but their over-activation can also instigate tissue damage leading to various autoimmune and inflammatory disease conditions. As approaches causing neutropenia are associated with immunodeficiency, targeting aberrant neutrophil infiltration offers an attractive strategy in neutrophil-centered diseases including acute lung injury. Rho GTPase family proteins Rho, Rac and Cdc42 play important role as regulators of chemotaxis in diverse systems. Rho inhibitors protected against lung injuries, while genetic Rho-deficiency exhibited neutrophil hyperactivity and exacerbated lung injury. These differential outcomes might be due to distinct effects on different cell types or activation/ inhibition of specific signaling pathways responsible for neutrophil polarity, migration and functions. In this study, we explored neutrophil centric effects of Rho signaling mitigation. Consistent with previous reports, Rho signaling inhibitor Y-27632 provided protection against acute lung injury, but without regulating LPS mediated systemic increase of neutrophils in the circulation. Interestingly, the adoptive transfer approach identified a specific defect in neutrophil migration capacity after Rho signaling mitigation. These defects were associated with loss of polarity and altered actin dynamics identified using time-lapse in vitro studies. Further analysis revealed a rescue of stimulation-dependent L-selectin shedding on neutrophils with Rho signaling inhibitor. Surprisingly, functional blocking of L-selectin (CD62L) led to defective recruitment of neutrophils into inflamed lungs. Further, single-cell level analyses identified MAPK signaling as downstream mechanism of Rho signaling and L-selectin mediated effects. p-AKT levels were diminished in detergent resistance membrane-associated signalosome upon Rho signaling inhibition and blockade of selectin. Moreover, inhibition of AKT signaling as well as selectin blocking led to defects in neutrophil polarity. Together, this study identified Rho-dependent distinct L-selectin and AKT signaling mediated regulation of neutrophil recruitment to inflamed lung tissue.
Identifiants
pubmed: 34425130
pii: S0167-4889(21)00176-2
doi: 10.1016/j.bbamcr.2021.119122
pii:
doi:
Substances chimiques
Amides
0
Enzyme Inhibitors
0
Pyridines
0
Reactive Oxygen Species
0
Selectins
0
Y 27632
138381-45-0
Proto-Oncogene Proteins c-akt
EC 2.7.11.1
rho GTP-Binding Proteins
EC 3.6.5.2
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
119122Informations de copyright
Copyright © 2021 Elsevier B.V. All rights reserved.